CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP)

US23254L2079

6.3  -0.06 (-0.94%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
420.00K0.000.000.000.00
Operating Expenses
25.87M27.66M22.94M10.64M9.68M
Research and Development
19.16M20.27M15.48M4.76M4.66M
Selling, General, and Administrative Expenses
6.72M7.38M7.46M5.88M5.02M
Operating Income
-25.45M-27.66M-22.94M-10.64M-9.68M
Interest Income/Expense
-148.00K440.00K60.00K60.00K330.00K
Other Income/Expense
50.00K1.30M140.00K890.00K230.00K
Income Before Taxes
-25.55M-25.92M-22.73M-9.68M-9.13M
Income Tax
-3.00M-4.72M-3.85M-1.24M-1.30M
Net Income
-22.76M-21.40M-19.09M-12.42M-8.03M
EBITDA
-25.42M-27.63M-22.90M-10.62M-9.66M
 
Per Share Data
EPS Diluted Total Ops
-26.75-1.90-2.14-3.42-9.79
Non GAAP EPS
-27.23-10.30-2.14-3.87-10.00
 
Statistics
Profit Margin
-5418.10%N/AN/AN/AN/A
Operating Profit Margin
-6060.24%N/AN/AN/AN/A

All data in USD

Charts